A Shanghai firm's innovative diabetes drug gains approval in Hong Kong, offering patients a new treatment option.
Treatment Stories
10 stories
Federal regulators commit to improving and streamlining approval processes for gene therapies treating rare diseases.
A US donation is funding research into a potential new treatment approach for rheumatoid arthritis.
An innovative medical breakthrough now allows many patients to avoid the risks and recovery time associated with open heart surgery.
FDA announces plans to accelerate approval timelines for rare disease treatments, benefiting patients in need.
Two promising new Parkinson's therapies advance to final clinical trial stages, bringing hope to patients.
A comprehensive overview of 2025 FDA approvals highlights numerous new treatment options for patients.
Top FDA approvals of 2025 highlight significant advances in pharmaceutical innovation and patient care.
Emerging research explores potential curative approaches for diabetes management.
Significant advances in type 2 diabetes treatments developed in China are now spreading globally to benefit patients worldwide.